AB
AEON BiopharmaClinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to Botox, for therapeutic indications like cervical dystonia and chronic migraine.
1 Pulse story
S
ShionogiJapanese pharmaceutical company developing prescription drugs, infectious disease therapies, and specialty medicines, including a former sleep apnea drug joint venture with Apnimed.
2 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2013
Founded
1878
Irvine, California
HQ
Osaka, Japan
Public (AEON)
Status
Public (4507.T)
AEON Biopharma investors
No investors on record.
Shionogi investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for AEON Biopharma and Shionogi.